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Abstract 
Ulcerative colitis (UC) is a disease characterized by inflammation of the GI tract, which disturbs 
the mucosal lining and hinders magnesium (Mg2+) absorption. Research has shown that 
increasing the dietary intake of Mg2+ decreases the severity of the colitis symptoms, but there is 
no data on the effect this has on the microbiota of the GI tract or the blood. We found that, in 
DSS-treated mice, the amount of bacteria in the colon increases with a decrease in dietary 
Mg2+, and that the concentration of bacteria in the spleen does not correlate to symptom 
severity or to colonic bacterial amounts. Mg2+ could be used as a supplement for UC patients, 
treating both hypomagnesemia and lowering colonic bacteria closer to healthy levels. 
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Introduction 
Magnesium 
 Magnesium is a vital ion in regard to physiology. It is the second most abundant 
intracellular cation, and the fourth in the entire human body (6). It is involved in many 
pathways of importance, like the degradation of macronutrients, regulation of parathyroid 
hormone, and excitability of neurons (6). Even further, it has a major role in the process of 
inflammation. The presence of magnesium limits transport of calcium into cells. Since calcium is 
known to trigger an inflammatory response, the absence of magnesium would enhance calcium 
influx and therefore increase the magnitude of inflammation. (3, 5).This interaction is crucial 
when it comes to inflammatory bowel diseases (IBDs). 
IBDs and the mouse model 
 IBDs are a growing concern in medicine. They are more common than epilepsy or car 
accidents, and have a comparable prevalence to type 1 diabetes or schizophrenia (8). This 
paper will focus on ulcerative colitis (UC), which is a bowel disease associated with 
inflammation of the superficial layer of the colon mucosa (8). It is obviously unethical to induce 
this condition in humans for research studies, but there are methods to do so in mice. One such 
procedure uses the chemical agent dextran sodium sulfate (DSS) to bring about comparable UC 
condition. Such a method is popular for research on therapeutic agents, and is known to be a 
sensitive screening model. It should be mentioned that this model does not require responses 
from B or T cells, and that luminal bacteria may have a role in colitis development (4).  
Microbiome 
 Gut microbiome plays a role in the development of IBDs like UC. In humans, the bacteria 
that are known to have an impact are the presence of the Proteobacteria phylum and the 
absence of diversity in the Bacteroidetes and Firmicutes phyla. In fact, chronic IBDs are often 
linked to previous acute inflammation of the gastrointestinal tract incited by bacteria (2). Diet 
has an effect on the diversity of the gut microbiome. Research has shown that a deficiency in 
magnesium concentration in the gut decreased the cecal concentration of Bifidobacteria and 
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Lactobacilli, of which the former is known to enhance mucosal barrier performance (3). The 
content of the flora of the gut can impact onset and development of IBDs, but at the same time 
can be impacted by the subject’s diet.  
Magnesium and UC 
 The development of UC is impacted by the intake of dietary magnesium. Subjects with 
an IBD suffer from a magnesium deficit, which when reverted lessens their symptoms. UC itself 
creates a cycle of hindering magnesium absorption through intestinal inflammation, which in 
turn increases the disease activity (7). Research has shown that the presence of magnesium has 
an impact on the diversity of the gut microbiome. This microbiome also has an impact on the 
mucosal lining, and therefore UC. Furthermore, the presence of magnesium impacts the 
virulence of bacteria. Salmonella is the typical model for this research, as it has systems to 
regulate virulence and allow survival in macrophages. These system also controls magnesium 
transporters, and it is hypothesized that low magnesium levels signal the virulence pathway (1). 
Research Aims 
 This study attempts to find the impact UC and dietary magnesium manipulation has on 
the gut microbiome of mice. The experimental diets vary in magnesium concentration, from 
severely depleted to normal feed levels, and UC was induced through the use of the chemical 
agent DSS. A variety of factors were observed to determine and classify a change in the 
microbiome of the gut as a result of the UC and dietary magnesium manipulation, 
Experimental Procedure 
Animal Environment 
In house bred black-6 mice [C57BL/6J (Harlan, Madison, WI USA)] were kept in a room 
of constant temperature and humidity (22-26⁰C and 56-70% humidity) with a light:dark cycle of 
12 hours. Both sexes were used for these experiments, although the number of each in the 
experimental groups remained constant. Similarly, age and litter were controlled throughout 
the groups. Males and females were kept in static cages and topped with wire. They were kept 
with other littermates of the same sex, in order to discourage fights between them. Each cage 
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contained a small amount of bedding [Sani-chips manufactured by TEklad], shredded paper for 
nesting, and a section of PVC pipe for enrichment.  
Diet Preparation 
A DSS (colitis grade; MP Biomedicals) solution was made to be as drinking water for 
experimental mice. This was done with deionized water that was run through a 10-minute 
liquid cycle in the autoclave. The DSS was then added to be 3% by mass for the bacterial 
analysis tests, and 2% by mass for the gut permeability tests (to lessen the devastative 
symptoms of the induced UC). The control diet (0.2% Mg; Teklad TD.130120, Harlan Teklad, 
Madison, WI, USA) and the depleted diet (0.003% Mg; Teklad TD. 93106, Harlan Teklad, 
Madison, WI, USA) were given ad libitum.  
Anesthesia Preparation 
The anesthesia used within this lab was 4% Avertin. This was prepared by adding 1 g of 
2, 2, 2-tribromoethanol to 1 ml 2-methyl 2-butanol. This solution was mixed vigorously with a 
stir bar in a container covered with aluminum foil to prevent interaction with light. Once the 2, 
2, 2-tribromoethanol dissolved fully, 1 ml of the solution was added dropwise to 40 ml of 150 
mM NaCl solution. This container was also wrapped in aluminum foil, and the solution was 
mixed until fully dissolved and presented as clear and precipitate free. The solution was then 
transferred to an amber glass bottle and stored in the refrigerator. 
Experimental Procedure 
 8-10 week old Black-6 mice were weighed and split into 2 groups: magnesium control 
and magnesium free. The magnesium free received the depleted diet, and the other received 
the control diet ad libitum. Each group was then further divided to determine which received 
the DSS treated drinking water. Both received purified deionized water (DIW), but the DSS 
treated mice had the 3% DSS solution. The drinking bottles were autoclaved prior to the start of 
the experiment, and the DSS solution was changed every two days. 
The subjects were given their respective diets and treatments for 6 days, and were 
weighed and tested for fecal occult blood daily. Feces were collected and smeared on filter 
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paper. They were then each coated with 120-150 mg of powdered guaiac tablets [Cambridge 
Diagnostic Products]. Each received two drops of glacial acetic acid followed by two drops of 3% 
Hydrogen peroxide [CVS]. A positive result presented with blue streaks extending around the 
sample before two minutes expired, while a negative yielded no color change with the same 
time limit. On the 6th day, the subjects were transferred to metabolic cages. Each was supplied 
with a known amount of food and DSS treated or untreated drinking water. After 24 hours, the 
mice were removed to be weighed, and the remaining amount of food and water was recorded. 
Urine from each subject was measured with a pipette, and 1 ml was collected for determination 
of magnesium concentration. Each sample was placed in an accuSpin Micro 17 and centrifuged 
at 13,000 RPM for 3 minutes. The supernatant from each was transferred to a clean microfuge 
tube and placed in the freezer for future analysis. After determining the mass of each mouse, 
they were anesthetized with 4% Avertin by intraperitoneal (IP) injection (300-400 μL). Total 
anesthesia was evidence by the absence of the pedal reflex. Mice were then dissected via 
ventral incision, blood samples were collected via intracardiac (IC) puncture, and the spleen and 
colon were removed. Blood samples were placed in clean microfuge tubes and allowed to clot 
for 30 minutes. They were then centrifuged for 10 minutes at 6,000 RPM, and the serum 
samples were transferred to clean microfuge tubes via pipette. These were kept at 4oC in the 
refrigerator until atomic absorption analysis was performed within one day of collecting the 
samples.  
Disease Activity Index 
 A disease activity index (DAI) was created in order to adequately quantify the presence 
of UC. This was done with known symptoms of UC, such as weight loss, presence of blood in the 
anus, positive fecal occult blood test, and loose stool. Mice received a score out of five: 1 point 
for weight loss 3% or greater (in one week), 2 points for weight loss greater than 10%, 1 point 
for the presence of blood in the anus, 1 point for a positive fecal occult test, and 1 point for 
loose stool (stuck to sides of the cage). 
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Atomic Absorption 
 The atomic absorption analysis was performed with a GBC 932 atomic absorption 
spectrometer. Serum samples were diluted in 1:200 in DI water and compared to a standard 
curve made with varying concentrations of magnesium chloride solution (0.0025 mmol, 0.005 
mmol, 0.0075 mmol, 0.01 mmol and 0.02 mmol). Urine samples were diluted 1:2000 to fit the 
same standard curve (although the control diet had to be diluted 1:3000 and 1:4000 to fit). 
Samples were run through the machine until the reading reached a maximum value and 
stabilized, beginning with the standards and following with the samples.  
Dissections 
 The removed spleen was cut into pieces under sterile conditions and homogenized in a 
solution of .01% Tween and 10% 10X PBS, at a volume nine times that of the spleen mass. 
Samples were placed in the refrigerator until they could be plated. After the spleen removal, 
the colon was taken out (cut just above the cecum and at the very end of the rectum) and 
measured. All were placed in chilled PBS for a photograph.   
Microbiology 
All microbiology procedures were performed by Dr. Pelletier’s lab. After collection, fecal 
and spleen samples were made into a slurry in 5 ml of 0.010% Peptone and L-cysteine water. 
These were vortexed, and 100 μl were plated on MRS, Bifidobacteria, and EMB agar. 50 μl of 
the original slurry was also added to 5 ml of the original mixture (0.010% Peptone and L-
cysteine water), of which 100 μl was plated on the BHI agar. The MRS and Bifidobacteria plates 
were incubated with 5% carbon dioxide at 37⁰C for 24 hours. The EMB and BHI plates were 
incubated at 37⁰C for 24 hours and did not receive the carbon dioxide. The colonies on all 
plates were then counted and converted to cells per gram. Medium composition are as follows: 
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Gut Permeability 
A FITC-Dextran (4 kDa, 25 mg/ml; Abbott Laboratories) intestinal permeability assay was 
used to determine a possible change in the gut permeability due to magnesium and DSS-
treatment. The process began with the removal of the mouse food and the transfer of mice to 
different cages with no bedding, but with the same drinking water.  
After 4-6 hours, an oral gavage was performed with 200 μl of a solution of FITC-dextran 
and sterile 1x PBS (1:2 dilution/0.625 μmol FITC-Dextran for the mice with no DSS treatment, 
and 1:4/0.3125 μmol FITC-Dextran for the DSS treated group). Mice were put under anesthesia 
in a container in the fume hood, which had wire above a stir bar and cotton bedding. The 
Table 1. Media components 
BHI Medium 
Ingredients per liter of deionized 
water:  
Calf Brain-Beef Heart Infusion 17.5g 
Pancreatic Digestion of Gelatin 10.0g 
Sodium Chloride 5.0g Disodium 
Phosphate 2.5g Dextrose 2.0g Final 
pH 7.4 +/- 0.3 at 25ºC. 
MRS Agar 
Ingredients (per liter of 
deionized water): 
 Proteose peptone 10 g 
 Beef extract 10 g  
Yeast extract 5 g  
Dextrose 20 g  
Polysorbate 80 1 g  
Ammonium citrate 2 g  
Sodium acetate 5 g  
Magnesium sulfate 0.1 g  
Manganese sulfate 0.05 g 
Dipotassium phosphate 2 g  
Final pH ( at 25°C) 6.5±0.2 
EMB Agar 
Ingredients per liter of deionized 
water:  
Pancreatic Digest of Gelatin 10 g 
Lactose 1 g 
 Dipotassium Phosphate 2 g  
Eosin Y 0.4 g 
Methylene Blue 65 mg 
 Agar 15.0 g Final pH 7.1 +/- 0.2 at 
25°C. 
Bifidobacterium Agar 
Ingredients (per liter of deionized 
water):  
Special peptone 23 g  
Sodium chloride 5 g  
Glucose 5 g Starch, soluble 1 g 
 L-Cysteine hydrochloride 0.3 g  
Agar 15 g 
 Final pH (at 25°C) 6.8±0.2  
Following sterilization, add (all 
sterile): 10 ml of 300 mg/ml lithium 
chloride  
1.5 ml of 10 mg/ml nalidixic acid  
2 ml of 50 mg/ml neomycin sulfate 
 4 ml of 50 mg/ml paramomycin 
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bedding was doused with 300 –400 µl isofluorane upon placement of mouse on the wire.. 
Anesthesia lasted 2-3 minutes, enough to perform the oral gavage. 
After 4 hours, blood was collected through the same process as magnesium 
determination. 400 µl of the blood sample was placed in a microfuge tube with 6 µl of Na 
heparin to prevent clotting. This was spun at 6,000 RPM for 10 minutes in a centrifuge, and the 
plasma was transferred to a clean tube and stored in the refrigerator until testing.  
Testing of the fluorescence was done with the use of a Synergy H1Hybrid Multi-Mode 
Reader (BioTek). A standard curve was created with 110 µl of a solution containing 0.0205 pmol 
FITC-dextran, 11 μl normal serum, and 98.9 µl PBS placed in the first well. 11 µl was removed 
from the well and transferred to well 2, which contained 99 µl of PBS and 10% FITC free serum. 
This continued until 6 wells contained dilutions of the original mixture. One well contained only 
99 µl of PBS and 10% FITC free serum to serve as a blank. The plasma of the experimental 
groups was then placed in following wells in a 1:10 dilution with PBS and kept in the dark until 
testing could commence. 
 
Results 
The DAI shows the impact that magnesium has on the progression of UC and its 
symptoms. Figure 1 shows the variation in the severity of symptoms amongst the groups:  
Carlson 9 
 
 
Both the control diet and magnesium depleted subjects without the DSS treatment had an 
average score of 0.167/5. The DSS treated group shows an actual difference, with the control diet 
having an average score of 2.50/5 and the depleted 3.50/5. A staggering difference can be seen 
across treatment groups as well (ANOVA followed by Fisher’s LSD, P<0.05). 
Analysis of Mg2+ concentration in serum and urine shows how much magnesium is being 
absorbed and how much is being excreted in different diet and treatment groups. Serum results 
can be seen in figure 2. 
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Mg2+ manipulation has a large 
impact on UC affected mice. 
Mice with the depleted Mg2+ 
diet experienced a much 
higher degree of symptoms 
compared to the control diet 
with DSS. The untreated 
groups were the same and 
considerably lower than the 
treated. 
Figure 1. Effect of Mg2+ Manipulation on UC 
Symptoms
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The control diets had the highest average concentration in their treatment groups. Control 
diet and untreated had an average of 1.395 mmol, and the same diet but with the DSS-treatment 
had 1.350 mmol. Both are within the normal range of 1.2-1.4 mmol. The depleted magnesium 
groups, however, did not reach the normal concentration. Magnesium free with no treatment had 
an average of 0.643 mmol, and the DSS-treated with the same diet had 1.027 mmol . (ANOVA 
followed by Fisher’s LSD, P<0.05). The difference between Mg2+ control with DSS and Mg2+ 
control without DSS is not significant (P-value of 0.114), although the rest of the data is below 
0.05. 
 The Mg output in the urine can be used to determine how much dietary magnesium is 
excreted by the body. Urine was collected over a period of 24 hours and tested in the same 
manner as the serum. Figure 3 shows the average concentrations for the different experimental 
groups. 
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Serum was separated from 
collected blood with a 
centrifuge and tested 
through atomic absorption. 
The control diet had the 
highest average values in 
both untreated and DSS-
treated groups. Normal 
Mg2+ is 1.2-1.4 mmol, 
which the depleted diets did 
not reach. 
Figure 2. Effect of Mg2+ Manipulation on Serum Mg2+ Concentration of 
Experimental Groups 
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 Magnesium manipulation and UC severely impacts the amount of magnesium excreted 
in urine. The control diet and without treatment had an average concentration of 41.36 μmol, 
and the same diet with the DSS treatment contained 18.65 μmol. The depleted diets were very 
low, at 1.37 and 0.970 μmol, for the untreated and treated respectively (ANOVA followed by 
Fisher’s LSD, P<0.05). The difference between Mg2+ free with DSS and Mg2+ free without DSS is 
statistically insignificant (P-value of 0.928) although the rest of the data is significant.  
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Urinalysis is vital for observing 
the path of Mg2+. It shows 
what the body is discarding 
and how much is being 
absorbed. The control diets 
had a much larger 
concentration than the 
depleted, and the DSS-treated 
mice contained much less 
Mg2+ than the untreated. 
Figure 3. Mg2+ Manipulation and UC Effect on Urine Concentration 
of Mg2+ 
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The mass of the spleen was recorded after its removal, and is shown in figure 4. Spleen 
mass appears relatively constant between mice that had the same DSS-treatment. The Mg2+-
control diet with no DSS-treatment reported an average spleen mass of 0.056 g, and the Mg2+-
depleted diet was 0.054 g. The Mg2+-control diet with the DSS-treatment was significantly 
higher, at 0.105 g than the depleted, at 0.106 g (ANOVA followed by Fisher’s LSD, P<0.05). The 
difference between DSS untreated groups is not statistically significant (P= 0.818). Differences 
between Mg-free DSS and Mg-control DSS were equally insignificant (P= 0.380). 
 Following removal of the spleen, the entire large intestine was dissected from 
each subject. Their lengths are shown in figure 5. 
UC has a large impact on the 
mass of the spleen. There is a 
near doubling when 
comparing DSS-treated to 
untreated, and virtually no 
difference between the 
different Mg2+ diets. 
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Figure 4. UC Effect on Spleen Mass 
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There appears to be a relationship between induced UC and colon length. Mice that 
were subjected to depleted dietary magnesium and DSS treatment had a colon shortened to a 
length of 43 mm. When not subjected to the DSS treatment, the average Mg2+-depleted diet 
mouse had a length of 50 mm.  The UC seemed to have little effect on the Mg2+-control diet 
group, with the DSS- untreated having a length of 52 mm and the DSS- treated 49 mm. There is 
no significant difference between the Mg2+-control diet with or without DSS and the Mg2+-
depleted diet without DSS. This difference is most notable from the Mg2+-depleted DSS- treated 
group compared to all other groups (ANOVA followed by Fisher’s LSD, P<0.05). 
 Bacteria was cultured from fecal material to analyze the microbiome of the gut. It was 
plated on various media to determine amount and composition. This is shown in figure 6. 
 
 
 
 
When induced with UC or 
magnesium intake is 
decreased, the colon 
length tends to shorten 
slightly. This is most 
noticeable in mice with a 
magnesium free diet. 
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Figure 5. UC and Mg2+ Effect on Colon Length 
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Figure 6. Effect of UC and Mg2+ Manipulation on Fecal Bacteria 
7.00E+08 
5.00E+08 
3.00E+08 
1.00E+08 
0 
BHI 
7.00E+08 
5.00E+08 
3.00E+08 
1.00E+08 
0 
Bifidobacterium 
7.00E+08 
5.00E+08 
3.00E+08 
1.00E+08 
0 
EMB 
7.00E+08 
5.00E+08 
3.00E+08 
1.00E+08 
0 
MRS 
(A) 
(C) (D) 
(B) 
Fecal samples were collected and grown on different types of media for analysis. BHI (A) is nonselective and nourishing, 
and allows for all culturable bacteria to grow. Groups that received no DSS treatment had about the same amount growth. 
The DSS treated control diet group showed a jump in the amount of growth, but the magnesium depleted with DSS had 
more than 10 times that of any other group. MRS (B) selects for lactobacilli, which seems to be affected more by the lack 
of magnesium than the BHI. Both control diets were about the same, while there was a slight increase in growth (1.5 times 
more) in the depleted and untreated group. Depleted diet and DSS treatment showed a huge amount of growth at around 
5.18E+08 colony forming units (CFUs). EMB (C) selects for gram negative bacteria. This plate follows a similar trend to the 
BHI plate; the control and depleted diets without treatment have very low CFUs, the control diet with the treatment has 
1000 times more, and the depleted and treated has about 4.58E+08 CFUs (10 times that of the control diet with 
treatment). The Bifidobacterium (D) plate is self-explanatory. The only group that showed significant growth is the 
depleted and treated, at 1.99E+08. The rest showed no significant growth. 
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 Bacterial analysis of the fecal material sample shows that the group with depleted 
magnesium and induced with UC contained the greatest amount of varying types of bacteria. 
The BHI agar is nonselective and permits growth of most bacteria; it is used primarily to 
compare total amounts. The highest in this media were the ones treated with DSS: the 
magnesium depleted had a total of 5.18E+08 CFUs, while the Mg2+-control diet had 3.88E+07 
CFUs. DSS-untreated groups had about the same values, as the Mg2+-control diet had 1.10E+07 
and the Mg2+-depleted had 1.35E+07. The MRS agar selects for lactobacilli, and the highest 
growth on this plate was from the magnesium depleted with UC treatment with 4.13E+08 CFUs. 
The next highest was the Mg2+-control diet with treatment at 1.24E+07, followed by Mg2+-
control diet DSS-untreated at 8.47E+06, and lastly magnesium free DSS-untreated, at 6.99E+06. 
EMB agar is for gram negative bacteria, and does not permit the growth of gram positive. 
Again, this plate really depended on the UC treatment. Mg2+-depleted without the DSS 
treatment had 4.58E+08 CFUS, while the control diet with treatment had 1.4E+07 CFUs. The 
untreated groups are much lower than these values: the Mg2+-depleted diet had 1.3E+04 CFUs, 
while the control diet had no growth whatsoever. Finally, the Bifidobacterium plate selects only 
Bifidobacterium. The magnesium control without DSS treatment had the lowest value, at 
6.94E+04. Next was the magnesium depleted without DSS treatment at 3.03+05 CFUs and the 
magnesium control with UC treatment at 2.02E+06. The highest was the Mg2+-depleted diet 
with DSS treatment, which had 1.99E+08 CFUs. 
 Spleen homogenate was also plated to observe UC disease progression throughout the 
body. Figure 7 shows the amount of colony forming units from each of the media used. 
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Culturing the bacteria from the spleen shows what types and what amount made it into 
the blood stream. The BHI agar showed that the highest amount of general growth belonged to 
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Figure 7. Effect of UC and Mg on Spleen Bacteria 
(A) (B) 
(D) 
(C) 
Bacterial cultures from spleen homogenate were grown to see the effect of UC and Mg on bacteria in the 
blood. On the BHI agar, Mg-Ctrl with DSS (A) had the highest amount of growth, followed closely by Mg-free 
no DSS. In the MRS agar (B), Mg-free with DSS had the most growth, with the Mg-ctrl with DSS having about 
half as much CFUs. The EMB media (C) only displayed growth on the DSS treated plates, with Mg-ctrl having 
almost 10 times more colonies than Mg-depleted. The Bifidobacterium agar (D) had growth in three groups, 
starting with Mg-ctrl no DSS, followed by Mg-free with DSS at double the first, then Mg-ctrl with DSS doubling 
that. 
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the Mg-ctrl with DSS diet, at 7577.27 CFUs. This was followed by Mg-free without DSS (6063.64 
CFUs), then Mg-free with DSS (3409.09 CFUs) and lastly Mg-free no DSS (1513.64 CFUs). MRS 
agar followed a trend similar to that of the fecal MRS plate. The untreated groups had the least 
amount of growth, with Mg-free displaying no colony forming units, and Mg-ctrl having 759.09 
CFUs. Next was the Mg-ctrl with DSS treatment, at 5304.54, which was doubled by the Mg-free 
with DSS at 11818.18 CFUs. From there, the similarity to the fecal bacteria ends. It is important 
to note that for these plates the N=3. In the EMB agar, both DSS-untreated groups had no 
growth. The Mg-free with DSS had 6913.64 CFUs, and the Mg-ctrl had 6135.00 CFUs. The 
growth of Bifidobacterium was stimulated by the presence of magnesium. Mg-depleted without 
DSS had zero colonies, and the Mg-ctrl without DSS had 15136.36 CFUs. Mg-free with DSS had 
30300.00 CFUs, which was nearly doubled by the Mg-ctrl with DSS at 62863.63 CFUs. 
Fitc-Dextran was used to determine the permeability of the gut and how it is related to 
UC and magnesium intake. Resulting data is shown in Figure 8. 
When treated with DSS, the gut permeability increases radically. The control diet had an 
average Fitc concentration of 8.17 pmol/L, while the depleted diet had one of 8.19 pmol/L. No 
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treatment groups were very low, with the control at 2.14 pmol/L and the depleted at 1.57 
pmol/L. None of these groups are statistically significant.   
 
Discussion 
 The present study compares symptoms and features of DSS-induced UC after depleting 
magnesium intake. It finds that a diet devoid of magnesium causes significant physiological 
changes and that the content of both the gut and spleen microbiome is altered. After a week of 
receiving the UC-inducing treatment, mice on a diet of 0.003% magnesium experienced more 
severe symptoms than those on a 0.2% diet (figure 1). The Mg2+-depleted group scored on 
average 3.5/ 5 DAI, while the Mg2+-control diet group scored 2.5/5, showing significantly 
reduced symptoms. Both Mg2+-depleted and control diets experienced the same amount of 
symptoms without the DSS treatment, allowing the attribution of the symptoms to fall on the 
amount of magnesium. It has been found in previous studies that magnesium helps to restore 
mucosal integrity and channel expression, which is what must be occurring here (5). While the 
increasing intestinal bacterial content mirrors the worsening of symptoms in the DAI, the 
spleen microbiome points in a different direction.   
 DSS-treatment altered the amount of magnesium that was absorbed in the body and 
excreted from it. Mucosal damage from UC occurs in the colon, which is the final location 
where significant absorption of magnesium and other solutes takes place. Data should show 
that the serum magnesium is low in the Mg2+-depleted DSS-untreated group and even lower in 
those with the DSS-treatment. Instead, the DSS-treated Mg2+-depleted group showed 1.027 
mmol/l of serum magnesium, while the DSS-untreated and Mg2+-depleted had 0.643 mmol/ of 
serum Mg2+ (Figure 2). Both of these values are below the normal range of 1.1-1.4 mmol. The 
increase in serum Mg2+ observed in the DSS-treated group might be explained by the Mg2+- 
being reabsorbed at the intestine from hemolyzed erythrocytes. Another possibility is that the 
average 24-hour water consumption in the DSS-treated group was 1.1 ml, which is not even 
half of the 2.4 ml averaged by the untreated group. Such a small intake would decrease blood 
volume, driving up the apparent magnesium concentration. This possibility could be tested in 
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the future by measuring the hematocrit of magnesium deprived mice with our without DSS 
treatment. The water consumption disparity is seen in the control diet as well, with the 
untreated drinking 2.8 ml and the DSS-treated drinking 2.0 ml. This could also explain the lack 
of difference between these two groups in regards to serum magnesium (untreated at 1.395 
mmol and DSS-treated at 1.350 mmol). 
 The amount of magnesium in the urine shows the body’s attempt to harbor the ion, in 
order to keep levels as close to normal as possible. A more complete picture could be obtained 
through fecal analysis, but the presence of fecal occult blood would have completely skewed 
that data. Excretion can only be viewed in this instance by urinalysis. It is easier to see the 
retaining of magnesium in the control diets, because they absorbed more to begin with. The 
highest value of μmol excreted in 1 day was 41.36 by the Mg2+-control DSS-untreated mice, 
followed by the control diet with the DSS-treatment at 18.65 μmol/day (figure 3). This shows 
that the excretion of the ion was limited after DSS-treatment, even in the control diet group. 
The depleted groups had very low amounts, from 1.37 μmol/day in the untreated and 0.970 
μmol/day in the DSS-treated.  
Physiological changes that are associated with this model of UC include colon shortening 
and the increased size of the spleen. Colon shortening occurs only in UC mice on a depleted 
diet. Spleen mass is different only across treatment groups; the mice receiving the DSS-
treatment had a similar sized spleen to the others on the DSS-treatment, regardless of their 
diet. The same can be said for those not on the treatment (Figure 4 and 5). This data confirms 
results seen in previous research (5). 
Induced UC on its own, but especially when paired with depleted magnesium 
conditions, increases the amount and the type of bacteria within the microbiome of the colon. 
The removal of magnesium, without UC, does not show a marked increase in the general 
bacterial amount. Introducing UC in the control diet, however, more than doubles growth. 
Removing magnesium in a DSS treatment group raises the number of colony forming units 
more than 10 times that of the control diet with treatment (Figure 6). This data correlates to 
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the DAI and the severity of UC symptoms: the higher the DAI score, the higher the amount of 
bacteria present in the intestines. 
The combination of a lack in dietary magnesium with DSS-induced UC increases not only 
the amount of colony forming units in the colon, but also every type of bacteria tested for in 
this study: lactobacilli, Bifidobacterium, and gram-negative bacteria. This is something that has 
not been seen before in scientific journals. Previous research has shown that a decrease in 
magnesium decreases the presence of Bifidobacterium and lactobacilli, although there is no 
data on what happens in the presence of DSS-induced UC. It is known that the aforementioned 
lactobacilli enhances mucosal barrier performance, which would decrease the movement of 
bacteria into the blood stream (2). It should be viable to observe such a movement through the 
microbiome of the spleen and the permeability of the gut.  
UC inflames the colon, which decreases magnesium absorption and even further 
compromises the mucosal lining. This compromise would theoretically increase the gut 
permeability, allowing for the movement of intestinal bacteria into the bloodstream. Gut 
permeability analysis in this study found that there is no significant increase in permeability due 
to magnesium manipulation. 
The presence of bacteria in the spleen would show the amount and type that survived 
transport there by macrophages. An increase in splenic bacteria in the Mg-free DSS-treated 
group would prove that bacteria has a large role in the infection of UC and IBDs. What is seen 
instead is data that is contradictory and paradoxical, and does not match that of the intestinal 
bacterial analysis. The BHI plate is the easiest explanation of such a paradox. The lowest 
amount of growth is seen in the Mg-ctrl DSS-untreated group, which is expected. Next highest 
is Mg-free DSS-treated, followed by Mg-free DSS-untreated. The greatest amount of bacterial 
colonies in this media is the Mg-ctrl with DSS. This data does not allow for any conclusions 
regarding magnesium or UC to be drawn from it. The control diet without UC had the lowest 
value, but the control diet with UC had the highest. If this were the only data, it would be 
possible to assume that bacterial growth depends more on UC. The depleted magnesium 
groups refute this possibility, since the untreated was higher than the treated. Except for the 
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MRS agar, the data from the spleen analysis does not match that of the intestine. The MRS 
shows that the presence of lactobacilli is encouraged mostly by the lack of magnesium and the 
presence of UC. Without the UC, however, the bacteria require magnesium to grow. One of the 
only viable extrapolations from the other plates is that the gram-negative and Bifidobacterium 
require magnesium or UC to grow, and the combination of both increases growth. The data 
gained from the spleen refutes the idea that bacteria has an impact on the symptoms of UC, as 
the groups that had the highest amount of bacteria did not have the worse symptoms.   
  This study attempted to find a link between the alteration of magnesium intake and 
presence of UC with changes in gut microbiota. There was a change observed in the intestinal 
flora as a direct result of this manipulation, as the increase in bacterial types (gram-negative, 
lactobacillus, and Bifidobacterium) mirrored that in groups of worsened UC symptoms. The 
presence of magnesium in subjects that were induced with UC expressed less intense 
symptoms related to the disease and had a decreased amount of bacteria in the colon. This 
means that bacteria interact with magnesium and that directly impacts the progression of IBDs.   
Splenic bacterial analysis did not show any relation between magnesium and UC, nor did 
the gut permeability. This is due to the very few trials actually performed as the experimental 
process is very lengthy. Future research will try to expand on spleen analysis, to see the impact 
magnesium has on virulence and the ability to survive in macrophages. In patients with UC or 
other IBDs, magnesium supplements would help to return hypomagnesemia to normal levels, 
decrease severity of symptoms, and also lower colonic bacterial amounts closer to normal 
levels. Further research should also look at developing a specific magnesium supplement for 
patients with IBDs. 
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